A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors
Clinical trial NCT02983045 · COMPLETED
Trial details
- NCT number
- NCT02983045
- Sponsor
- Nektar Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-19
- Primary completion
- 2022-04-28
- Enrollment
- 557
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.